Cristina Mingot-Gonzalez
Lleida, CT 25198, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis.
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis.
Journal: Molecular neurobiology
Published: August 05, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months.
Journal: Journal of clinical medicine
Published: March 26, 2025
Exploring platelet metabolomics and fatty acid profiles for ALS prognosis and diagnosis.
Journal: Scientific reports
Published: March 17, 2025
Novel Cell Models to Study Myelin and Microglia Interactions.
Journal: International journal of molecular sciences
Published: January 28, 2025
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 30, 2024
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Journal: Journal of clinical medicine
Published: September 15, 2023
Reliability, validity and distribution of the Spanish female sexual function index in women with relapsing multiple sclerosis.
Journal: BMC women's health
Published: August 08, 2023
Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients.
Journal: Journal of clinical medicine
Published: April 04, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.
Journal: Scientific reports
Published: March 09, 2023
Ischemic encephalopathic debut of CADASIL, a case report: It is better to be safe than sorry.
Journal: Neurologia
Published: November 21, 2022
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.
Journal: Journal of neurology
Published: October 27, 2022
Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.
Journal: Brain communications
Published: September 14, 2022
Last Updated: 09/26/2026